Pernix Therapeutics Inc. to Present at the 26th Annual Piper Jaffray Healthcare Conference

Piper Jaffray Healthcare Conference 2014

MORRISTOWN, N.J.--()--Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX), a specialty pharmaceutical company, announced today that Douglas Drysdale, Chairman, President and Chief Executive Officer and Sanjay Patel, Chief Financial Officer, are scheduled to present at the Annual Piper Jaffray Healthcare Conference in New York, NY on December 2, 2014.

Event:     26th Annual Piper Jaffray Healthcare Conference
 
Date:

Tuesday, December 2, 2014

 
Time: 10:30-11:30 AM EST
 

A live webcast of the presentation will be available on the Pernix Therapeutics website, www.pernixtx.com, under the investor relations tab. A replay of the webcast will be available for 30 days after the date of presentation.

About Pernix Therapeutics

Pernix Therapeutics is a specialty pharmaceutical business with a focus on acquiring, developing and commercializing prescription drugs primarily for the U.S. market. The Company targets underserved therapeutic areas such as CNS, including neurology and psychiatry, and has an interest in expanding into additional specialty segments. The Company promotes its branded products to physicians through its Pernix sales force, uses contracted sales organizations to market its non-core, cough and cold products, and markets its generic portfolio through its wholly owned subsidiaries, Macoven Pharmaceuticals, LLC and Cypress Pharmaceutical, Inc.

To learn more about Pernix Therapeutics, visit www.pernixtx.com.

Contacts

Pernix Therapeutics Holdings Inc.
Investor Relations
Sanjay Patel, (800) 793-2145 ext. 1009
Chief Financial Officer
spatel@pernixtx.com
or
Doug Drysdale, (800) 793-2145 ext. 1001
Chairman, President and Chief Executive Officer
ddrysdale@pernixtx.com
or
Media Relations
Marianne Lambertson, (800) 793-2145 ext. 1012
Vice President, Marketing and Corporate Communications
mlambertson@pernixtx.com

Contacts

Pernix Therapeutics Holdings Inc.
Investor Relations
Sanjay Patel, (800) 793-2145 ext. 1009
Chief Financial Officer
spatel@pernixtx.com
or
Doug Drysdale, (800) 793-2145 ext. 1001
Chairman, President and Chief Executive Officer
ddrysdale@pernixtx.com
or
Media Relations
Marianne Lambertson, (800) 793-2145 ext. 1012
Vice President, Marketing and Corporate Communications
mlambertson@pernixtx.com